Article info
PDFAetiology/Harm
Cohort Study
Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults
- Correspondence to: Dr Prasad S Nishtala, School of Pharmacy, University of Otago, PO Box 56, Dunedin 9054, New Zealand; prasad.nishtala{at}otago.ac.nz
Citation
Cognitive adverse effects and brain deterioration associated with use of anticholinergic activity medicines in older adults
Publication history
- First published November 4, 2016.
Online issue publication
June 19, 2019
Article Versions
- Previous version (19 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/